chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/allergies or concurrent conditions were reported. On an unknown date in 2015 (reported as "2 years ago"), the patient received a dose of PNEUMOVAX 23 intramuscularly, for prophylaxis (the dose, anatomical location, lot # and expiration date were unknown). Subsequently, on 05-JAN-2017, the patient received another dose of PNEUMOVAX 23 (which had a lot # of M041686 with an expiration date of 20-MAY-2018; however, the dose, and anatomical location were not reported), intramuscularly, for prophylaxis as well. No concomitant therapies were reported as well. Despite this schedule of vaccinations, no adverse effects were reported. Additional information has been requested.
fibromyalgia pain in entire body, muscle cramps, stomach flu, fever, headache
This spontaneous report was received from a 38-year-old medical assistant who refers to himself. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 22-JUN-2017, at the age of 38, the patient was intramuscularly vaccinated with a dose of GARDASIL 9 (dose, lot# and expiration date were not reported). No side effects were reported. No product quality complaint (PQC) was involved. Additional information is not expected, because there was no consent to contact the reporter.
Pityriasis rosea; Rash; This is a spontaneous report from a contactable consumer (patients mother) reported for a patient (reporter's son) that:  A 12-year-old male patient received first dose of BNT162B2 (COMIRNATY; Solution for injection; Lot number: unknown) via an unspecified route of administration on 09Jun2021 (age at the time of vaccination: 12 years) as dose 1, single for COVID-19 immunization. Medical history of the patient were not reported. Family history included history of auto-immune disorder. Concomitant medications were not reported. On an unspecified date in 2021, few days after receiving first dose of vaccination patient experienced rash, pityriasis rosea that lasted beyond the 40-day mark. Patient was directed to not give his 2nd vaccination while he was still having this auto-immune rash. Patient have a history of auto-immune disorders in family and wanted to see if it was recommended if he did have a small auto-immune response to receive the second dose. The rash lasted for almost 2 months. Reporter mentioned that they saw the doctor on 06Jul2021, 10Jul2021, and another doctor in August. They both said it was pityriasis rosea and to report to Pfizer if he should get the 2nd vaccination. Reporter (mother) highest concern was that he had an auto-immune response rash. The rash itself was not a big deal, but we have a very strong auto-immune history in our family. Reporter (mother) have 2 auto-immune diseases and just wanted to make sure they were making an informed decision." Outcome of the events were resolved on an unspecified date in 2021.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This is a spontaneous report from a contactable pharmacist. A 21-year-old Asian female patient received the first dose of TRUMENBA, (Lot number: T41409 and Expiration date: Aug2019, NDC number: 0005-0100-10), intramuscular in left arm, on 29Nov2017 15:15 at 0.5 ml, single for prevention of Meningitis Group B. The patient received the vaccine through the protocol doctor for vaccines at a pharmacy. Medical history was reported as none. The patient's concomitant medications were not reported. No other vaccines were administered. The patient experienced muscle soreness in her entire body that began the night of 29NOV2017. She had a local reaction first and took Ibuprofen. She said that it was still sore today, but it felt like she did a lot of sit ups. The outcome of the event muscle soreness was recovering and for local reaction was unknown.
FELT ILL; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported) dose was not reported, administered on 09-MAY-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced felt ill. The action taken with covid-19 vaccine  was not applicable. The outcome of felt ill was not reported. This report was non-serious. This case, from the same reporter is linked to 20210522019.
Pt had been given MMR & 4th & final HIB vax mom brought pt back 1/2 hr later pt continually crying/whining, felt hot & mom stated just couldnt get comfortable; temp taken 101 ax, 102 .4; mom gave APAP;
first dose of Shingrix over 2 yeas ago; This case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received over 2 years ago from reporting date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The VAERS details were reported for 1st dose. The healthcare professional consented to follow up. This case had been linked to the case US2021226679, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021226679:Same reporter
Fever 100.9 day after vaccine, headache, soreness and redness at injection site.
On the way home she started feeling funny. Very tired, vagainal bleeding like a menstral cycle but very heavy.
This spontaneous report as received from a registered nurse refers to a 24 year old female patient. In 1994, the patient was vaccinated with the complete series of hepatitis B vaccine (recombinant) (manufacturer unknown) (Lot # not reported). The nurse reported that, "recently", on an unknown date, the patient had negative titer to hepatitis B. The outcome of negative titer to hepatitis B was unknown. This is one of several reports received from the same source. Additional information has been requested.
about 1 hrs p/vax pt was going down trailor steps & fainted-was unconscious; mom hurried to pt & pt came to mom saying I'm alright; did not see MD;
Child had received vaccine. After receiving vaccine, 10 minutes later c/o burning to injection site. Assessment-area red, warm to touch. Ice pack applied. Reassessed 15 min later. Site still red and child c/o burning still. BENADRYL 25 mg PO given. After 15 min, child stated "burning was better", site appeared less red and warm.
Significant fatigue for the past two months. Not able to do her normal day-to-day activities without taking a break or taking a nap.
Ran low grade fever on 2/6 at 100.8. Headache for most of 2/6. Swollen lymph node in armpit on same side as injection.
6 days after MMR and chicken pox vaccines, 102 fever, swelling of lymph nodes in groin (size of finger) loss of appetite, irritability, long duration of sleeping, gray color in skin, lethargy.
pt recv vax 26NOV96 & 18NOV97 devel zoster on rt arm from the rt forearm extending to rt hand & including a portion of the palm surface of  rt hand;also devel varicella 1-2mon p/vax;
Patient reports radiating arm pain in the left arm after getting his flu shot on 10/03/2020. He stated that it hurts to lift his arm. He had arm pain after getting the vaccine, and it got worse as time went on. He reports no redness or swelling.
Moderna as booster which threw me for a loop/Earlier stronger reaction seems it means it's doing more for my system; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Moderna as booster which threw me for a loop/Earlier stronger reaction seems it means it's doing more for my system) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer Covid Vaccine-BNT162b2 (2 Dose) and Pfizer Covid Vaccine-BNT162b2 (1 Dose). Past adverse reactions to the above products included No adverse event with Pfizer Covid Vaccine-BNT162b2 and Pfizer Covid Vaccine-BNT162b2.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Moderna as booster which threw me for a loop/Earlier stronger reaction seems it means it's doing more for my system). At the time of the report, VACCINATION COMPLICATION (Moderna as booster which threw me for a loop/Earlier stronger reaction seems it means it's doing more for my system) outcome was unknown.            No concomitant product use was reported.  The patient reported had 2 Pfizer dose then Moderna as booster which threw patient for a loop. The patient was thinking to take Moderna as second booster as patient earlier had stronger reaction seems its doing more for patient system.  No treatment information was provided.
Throbbing headache in occiput, dizziness and drowsiness.  improved wtih sleep.  Resolved on its own within 24 hours.
Received expired dose; vial that was punctured and left at room temperature for 5 days; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired dose) and PRODUCT STORAGE ERROR (vial that was punctured and left at room temperature for 5 days) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069F21A, 031B21A and 048A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Feb-2022 at 5:15 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 27-Jan-2022, the patient experienced PRODUCT STORAGE ERROR (vial that was punctured and left at room temperature for 5 days). On 01-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired dose). On 01-Feb-2022, EXPIRED PRODUCT ADMINISTERED (Received expired dose) had resolved. At the time of the report, PRODUCT STORAGE ERROR (vial that was punctured and left at room temperature for 5 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatment information was reported.  Vaccination location reported as deltoid.  It was reported that inadvertently expired doses were administered to 8 patients. The vial was initially stored in the refrigerator on 27-Jan-2022. The vial was first punctured on 27-Jan-2022, 8.30am. On 01-Feb-2022 at 2.30pm-4.30pm, the vaccine was administered. The vial was stored post puncture in RT. The vial did not undergo any temperature excursions. It was reported that no adverse event occurred.    Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2022: Significant Follow up, patient demographics and narrative updated.
About 14 hours after the vaccine I started feeling a fever coming on I took my temperature and it was 103.0 I also had body aches; joint pain; chills; fatigue and a headache. I am also experiencing ankle swelling and blurry vision that comes and goes. I also had my influenza and Shingles vaccine on the same day. So I'm not sure if this event is attributed to the COVID 19 vaccine. I am trying to schedule a follow up visit with an eye doctor and a cardiologist.
CONFIRMED COVID-19 INFECTION (LETHARGIC); CONFIRMED CLINICAL VACCINATION FAILURE; HEADACHE; FEELING WORN OUT; NAUSEA; This spontaneous report received from a patient concerned a 66 year old female of an unknown race and ethnicity. The patient's height, and weight were not reported. The patient's past medical history included chronic obstructive pulmonary disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 043A21A and expiry: unknown) dose was not reported, 1 total administered on 08-MAR-2021 for prophylactic vaccination. The patient could not recall the vaccination site. Concomitant medications were not reported. On 08-MAR-2021, after the vaccination, patient developed nausea, headache and felt really worn out for 3 days and then the symptoms went away. On 05-JUN-2021, the patient started to feel lethargic, wicked headache and the oxygen kept going low and the pulse rate was high. On 09-JUN-2021, the patient decided to get tested for COVID and the result went positive. The patient had confirmed clinical vaccination failure. Patient was hospitalised until 12-JUN-2021 and was probably to be discharged the next day. Patient stated that was taking a lot of medications including prednisone, antiviral and anti-bacterial drugs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, feeling worn out, and nausea on 11-MAR-2021, and the outcome of confirmed clinical vaccination failure and confirmed covid-19 infection (lethargic) was not reported. This report was serious (Hospitalization Caused / Prolonged). This report was associated with product quality complaint: 90000182633. The suspected product quality complaint has been confirmed to be not voided based on the PQC evaluation/investigation performed.; Sender's Comments: V0;20210626624-covid-19 vaccine ad26.cov2.s -confirmed clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS  V0;20210626624-covid-19 vaccine ad26.cov2.s -confirmed covid-19 infection . This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event
Information has been received regarding a case in litigation from a lawyer and refers to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, drug reactions or allergies were not reported. On approximately 04-OCT-2011 (reported as on or about 04-OCT-2011), the patient was vaccinated with ZOSTAVAX, (strength, route, anatomical location, dose, frequency, dose number, lot number and expiration date were not reported), for the permanent prevention and protection against shingles and zoster-related conditions/injuries (prophylaxis). No other suspect or concomitant therapies were reported. On an unknown date, the patient was diagnosed with shingles (herpes zoster) and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX (vaccination failure), and suffered serious physical, emotional, and economic damages as a result. In addition, the patient would continue to suffer ongoing injuries, included but not limited to: mental and physical pain and suffering (Emotional distress and pain), extensive medical care and treatment for these injuries, significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; diminished quality of life (Quality of life decreased); increased risk of premature death, aggravation of pre-existing conditions and activations of laten conditions (Condition aggravated), lost wages, loss of earning capacity and other losses and damages. On an unknown date in 2015, the patient was treated for shingles. At the time of report, the patient was not recovered from emotional distress and pain, and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased and the pre-existing unspecified conditions aggravated was unknown. The reporter considered all aforementioned adverse events to be related to ZOSTAVAX. The reporter determined adverse events as medically significant, disabling and life-threatening events.
Two days after receiving her PNEUMOVAX injection, patient's left arm became red below the injection site and sore at the injection site. Patient went to physician who prescribed an antibiotic.
Pt reported trip to emergency room with confusion and convulsions. this occurred the same day 10-14-19 but later in the evening the same day he received the vaccines.
Patient states nerve damage, pain, and weakness of left arm.  immunization was injected correctly and in right area.
I started to have symptoms on my first dose to my left upper jaw and tooth but I did not think anything at first. I went to the dentist to check out my tooth. I even got a CT scan of my jaw and it was not my tooth. I got then my second dose vaccine and my symptoms persisted. As the days went by, the pain radiated to the top of my head and shoulder. This pain I experienced came and went. I ended up calling my doctor and he gave me treatment for the pain. I have never experienced this kind of pain before, it was a neurological pain. My symptoms have resolved today and I have no pain today.
have both dosages of the Moderna vaccine, had minimum side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (have both dosages of the Moderna vaccine, had minimum side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced VACCINATION COMPLICATION (have both dosages of the Moderna vaccine, had minimum side effects). At the time of the report, VACCINATION COMPLICATION (have both dosages of the Moderna vaccine, had minimum side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided by the reporter.
About 48 hrs vaccines given, the patient was noted to have lethargy, unsteady gait, truncal ataxia, nystagmus, and dysarthria that lasted ~24 hrs.  No treatment was given.  5/27/2008 MR received for DOS 4/17-18/2008 with D/C DX:  Acute Cerebellar Ataxia (Cerebellitis).  Pt presented to ER with unstable gait and lethargy.  Pt was in usual state last night but was difficult to wake, irritable and kept falling asleep in am. (+) mental status changes as well as staring episodes.  PE (+) for ataxia and delayed finger to nose. Improvement noted o/n and d/c.
She received a tetanus booster and a pneumonia vaccine on her left upper arm at her HME on 5/2/2018. The day of her visit she felt fine. That night, she woke up once from arm pain during the night. She took Aleve which did not help. She states, "I am sure that I am fine." She had achy arm pain yesterday with a 100.6F temp. She took Tylenol which helped. Today, she took 2 Aleve at 7 AM this morning, and she has noticed less pain with arm movement. The pain is in her upper arm and neck area. She noticed red blotches on her upper arm today. No itching.
Diffuse itchy hives about 4 hours from administration of vaccine, 1 tsp Benadryl given immediately and patient returned to office for evaluation.
Symptoms since Covid vaccines; Symptoms since Covid vaccines; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single, and dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced symptoms since covid vaccines on an unspecified date. Outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
pt recvd vax at 3pm; had inc swelling in leg; high pitch scream; to er at 6:30; pmd said it was rxn to pertussis;
Infant born at 32 weeks gestation. Second of twins, female with hyaline membrane disease, severe respiratory acidosis (resolved), hypermagnesemia (resolved), hypocalcemia (resolved), presumed sepsis, not proven, apnea of prematurity, hyperbilirubinemia (resolved), dehydration (resolved), feeding intolerance (resolved).
extreme headache; Fever; Shivering; body ache; Diarrhea; Nauseated; been sick for 3 days; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In MAR-2023, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: been sick for 3 days), headache (Verbatim: extreme headache), fever (Verbatim: Fever), shivering (Verbatim: Shivering), general body pain (Verbatim: body ache), diarrhea (Verbatim: Diarrhea) and nausea (Verbatim: Nauseated). The outcome of the sickness was resolved (duration 3 days) and the outcome of the headache, fever, shivering, general body pain, diarrhea and nausea were not reported.   It was unknown if the reporter considered the sickness, headache, fever, shivering, general body pain, diarrhea and nausea to be related to Shingles vaccine.     It was unknown if the company considered the sickness, headache, fever, shivering, general body pain, diarrhea and nausea to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This non-serious case was reported by a consumer via interactive digital media. The patient just had his/her Shingles shots last Thursday and was sick for 3 days. Side effects on patient were extreme headache, fever, shivering, body ache, diarrhea and nauseated. The follow up would not be possible.
Pfizer-BioNTech COVID-19 vaccine.  Nearly immediately with numbness and decreased sensation to left pinky and ring finger.
Fever of 101, chills, body aches, head ache, dizziness, nausea - symptoms relieved with Tylenol.
Mentrual bleeding; This spontaneous case was reported by a consumer and describes the occurrence of INTERMENSTRUAL BLEEDING (Mentrual bleeding) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jun-2021, the patient experienced INTERMENSTRUAL BLEEDING (Mentrual bleeding). At the time of the report, INTERMENSTRUAL BLEEDING (Mentrual bleeding) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered INTERMENSTRUAL BLEEDING (Mentrual bleeding) to be possibly related.    No treatment was provided. No concomitant was provided.